Breaking News Instant updates and real-time market news.

BBBY

Bed Bath & Beyond

$11.54

0.11 (0.96%)

08:50
07/11/19
07/11
08:50
07/11/19
08:50

Bed Bath & Beyond price target lowered to $13 from $17 at Jefferies

Jefferies analyst Jonathan Matuszewski lowered his price target for Bed Bath & Beyond to $13 from $17 saying the company's sales and margins continue to disappoint. The analyst prefers to remain on the sidelines "until evidence of inflecting trends." He keeps a Hold rating on the name following last night's fiscal Q1 results.

  • 25

    Jul

BBBY Bed Bath & Beyond
$11.54

0.11 (0.96%)

04/11/19
MSCO
04/11/19
NO CHANGE
Target $20
MSCO
Equal Weight
Bed Bath's weak Q1 view calls FY19 guidance into question, says Morgan Stanley
Morgan Stanley analyst Simeon Gutman said he is skeptical Bed Bath & Beyond will be able to deliver results in line with its "overly optimistic" 2019 guidance given the company's weak Q1 outlook. He also questions the achievability of the company's "bullish" long-term guidance as he expects macroeconomic pressure and competitive headwinds to intensify. Gutman added that he believes Bed Bath's intention to accelerate its board refreshment process may not suffice and that the company could be headed towards a proxy fight with the activists that are involved in the stock. He keeps an Equal Weight rating and $20 price target on Bed Bath & Beyond shares.
07/09/19
LOOP
07/09/19
NO CHANGE
Target $12
LOOP
Hold
Bed Bath & Beyond price target lowered to $12 from $16 at Loop Capital
Loop Capital analyst Anthony Chukumba lowered his price target on Bed Bath & Beyond (BBBY) to $12 to reflect the "uncertainty" surrounding the company's management team and turnaround strategy, even though the most recent pricing study relative to Amazon (AMZN) saw a slight narrowing in pricing average to 10.6% from 12.5% premium in April. The analyst also maintains a Hold rating on Bed Bath & Beyond, saying the company has a long road ahead to reverse its long string of fundamental underperformance.
07/11/19
GSCO
07/11/19
INITIATION
Target $11
GSCO
Sell
Bed Bath & Beyond initiated with a Sell at Goldman Sachs
Goldman Sachs analyst Kate McShane started Bed Bath & Beyond with a Sell rating and $11 price target. Weak in-store trends and over-reliance on coupons as a traffic driver have led to significant pressure on sales and margins, McShane tells investors in a research note. She expects expect Bed Bath & Beyond will face ongoing sales declines and market share losses resulting from a high level of competition in the industry and continued challenges with its store fleet.
07/11/19
BARD
07/11/19
NO CHANGE
Target $13
BARD
Neutral
Bed Bath & Beyond price target lowered to $13 from $18 at Baird
Baird analyst Peter Benedict lowered his price target for Bed Bath & Beyond to $13 from $18 and maintained a Neutral rating following the company's quarterly results. In a research note to investors, Benedict says that while adjusted EPS exceeded expectations, a lower tax rate/share count was required to offset an EBIT shortfall. While management remains focused on stabilizing sales in fiscal 2020, Benedict says he sees "little evidence" of an inflection on the horizon without sacrificing margins.

TODAY'S FREE FLY STORIES

SYF

Synchrony

$36.09

0.54 (1.52%)

, PYPL

PayPal

$119.87

1.07 (0.90%)

08:00
07/19/19
07/19
08:00
07/19/19
08:00
Hot Stocks
Synchrony says average active accounts were up 9% in Q2 »

Synchrony (SYF) says it…

SYF

Synchrony

$36.09

0.54 (1.52%)

PYPL

PayPal

$119.87

1.07 (0.90%)

WMT

Walmart

$114.68

0.08 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 24

    Jul

  • 15

    Aug

  • 25

    Sep

  • 13

    Nov

NFLX

Netflix

$325.14

-37.36 (-10.31%)

08:00
07/19/19
07/19
08:00
07/19/19
08:00
Options
Netflix call buyer realizes 3% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

SKX

Skechers

$34.75

0.35 (1.02%)

07:59
07/19/19
07/19
07:59
07/19/19
07:59
Recommendations
Skechers analyst commentary  »

Skechers price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STT

State Street

$56.27

1.67 (3.06%)

07:55
07/19/19
07/19
07:55
07/19/19
07:55
Hot Stocks
State Street boosts productivity savings for FY19 to 4.5% from 4% »

State Street says it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 06

    Aug

WNS

WNS Holdings

$62.34

3.8 (6.49%)

07:53
07/19/19
07/19
07:53
07/19/19
07:53
Recommendations
WNS Holdings analyst commentary  »

WNS Holdings price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Aug

MSFT

Microsoft

$136.29

0.06 (0.04%)

07:52
07/19/19
07/19
07:52
07/19/19
07:52
Recommendations
Microsoft analyst commentary  »

Microsoft still has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

CRWD

Crowdstrike

$72.75

1.77 (2.49%)

07:51
07/19/19
07/19
07:51
07/19/19
07:51
Recommendations
Crowdstrike analyst commentary  »

Crowdstrike price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WW

WW

$25.18

1.23 (5.14%)

07:49
07/19/19
07/19
07:49
07/19/19
07:49
Upgrade
WW rating change  »

WW upgraded to Buy at DA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$136.29

0.06 (0.04%)

07:49
07/19/19
07/19
07:49
07/19/19
07:49
Recommendations
Microsoft analyst commentary  »

Microsoft price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

DOW

Dow Inc.

$51.76

0.15 (0.29%)

07:48
07/19/19
07/19
07:48
07/19/19
07:48
Initiation
Dow Inc. initiated  »

Dow Inc. initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 24

    Sep

NGVT

Ingevity

07:44
07/19/19
07/19
07:44
07/19/19
07:44
Downgrade
Ingevity rating change  »

Jefferies downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 06

    Aug

INDB

Independent Bank

$73.31

0.56 (0.77%)

07:44
07/19/19
07/19
07:44
07/19/19
07:44
Upgrade
Independent Bank rating change  »

Independent Bank upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

KBR

KBR

$25.28

0.36 (1.44%)

07:43
07/19/19
07/19
07:43
07/19/19
07:43
Upgrade
KBR rating change  »

KBR upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

MDR

McDermott

$10.20

-0.25 (-2.39%)

07:41
07/19/19
07/19
07:41
07/19/19
07:41
Hot Stocks
McDermott awarded pre-FEED contract by YPF in Argentina »

McDermott has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jul

ADTN

Adtran

$12.12

-3.72 (-23.48%)

, DTE

DTE Energy

$131.39

1.27 (0.98%)

07:41
07/19/19
07/19
07:41
07/19/19
07:41
Recommendations
Adtran, DTE Energy analyst commentary at MKM Partners »

Adtran price target…

ADTN

Adtran

$12.12

-3.72 (-23.48%)

DTE

DTE Energy

$131.39

1.27 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 26

    Jul

  • 02

    Oct

AXS

Axis Capital

, ACGL

Arch Capital

$38.24

0.12 (0.31%)

07:41
07/19/19
07/19
07:41
07/19/19
07:41
Recommendations
Axis Capital, Arch Capital, Travelers, Hartford Financial analyst commentary at Buckingham »

Buckingham upgrades Axis…

AXS

Axis Capital

ACGL

Arch Capital

$38.24

0.12 (0.31%)

TRV

Travelers

$152.69

0.27 (0.18%)

HIG

Hartford Financial

$57.90

0.24 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 30

    Jul

  • 31

    Jul

  • 02

    Aug

  • 06

    Aug

07:40
07/19/19
07/19
07:40
07/19/19
07:40
General news
Treasury Market Outlook: Treasuries are a little weaker »

Treasury Market Outlook:…

WNS

WNS Holdings

$62.34

3.8 (6.49%)

07:39
07/19/19
07/19
07:39
07/19/19
07:39
Recommendations
WNS Holdings analyst commentary  »

WNS Holdings price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Aug

ISRG

Intuitive Surgical

$536.44

13.25 (2.53%)

07:38
07/19/19
07/19
07:38
07/19/19
07:38
Recommendations
Intuitive Surgical analyst commentary at Canaccord »

Intuitive Surgical price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 09

    Sep

AXP

American Express

$128.40

1.355 (1.07%)

07:37
07/19/19
07/19
07:37
07/19/19
07:37
Earnings
American Express backs FY19 adj. EPS view of $7.85-$8.35, consensus $8.13 »

Backs FY19 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 13

    Nov

EXPO

Exponent

$61.63

0.83 (1.37%)

07:37
07/19/19
07/19
07:37
07/19/19
07:37
Recommendations
Exponent analyst commentary  »

Exponent price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

STT

State Street

$56.27

1.67 (3.06%)

07:37
07/19/19
07/19
07:37
07/19/19
07:37
Earnings
State Street reports Q2 EPS $1.42, consensus $1.39 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 06

    Aug

WW

WW

$25.18

1.23 (5.14%)

07:36
07/19/19
07/19
07:36
07/19/19
07:36
Upgrade
WW rating change  »

WW upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBBP

Strongbridge Biopharma

$2.77

-0.12 (-4.15%)

07:35
07/19/19
07/19
07:35
07/19/19
07:35
Hot Stocks
Strongbridge Biopharma announces new employment inducement awards »

Strongbridge Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXP

American Express

$128.40

1.355 (1.07%)

07:35
07/19/19
07/19
07:35
07/19/19
07:35
Earnings
American Express reports Q2 EPS $2.07, consensus $2.04 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.